Trial Profile
Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose, With Nested Cross-over for Food Effect, to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Aug 2019
Price :
$35
*
At a glance
- Drugs ACT 451840 (Primary)
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- Sponsors Actelion Pharmaceuticals
- 18 Jul 2014 New trial record